Who Controls the Healthcare Spice?

Who controls the healthcare spice?

The meteoric rise of CareBridge, why its success was a foregone conclusion, and how officials hopping between public agencies and private markets can exert outsized influence over unnoticed corners of healthcare.

Read More

CVS, Amazon Pharmacy, and Cost Plus Drugs: PBM Disruption or a Blip on the Radar?

Hospitalogy

In likely the biggest news headline of the week, BCBS CA and its 4.8 million member footprint announced its intention to ditch CVS and is replacing that 3-letter void with a consortium of vendors – Amazon Pharmacy for at-home drug delivery, Mark Cuban Cost Plus Drugs for benefit design and medication access, Prime Therapeutics, and Abarca to fill other existing drug benefit functions.

Read More

Physician Dynamics are Reaching a Boiling Point

Physician dynamics are reaching a boiling point - hospitalogy

In today’s send I wanted to aggregate and describe a number of factors facing physicians and physician employment in 2023. While I don’t necessarily have a conclusion here, it seems as if a number of these variables are slowly coming to a head across full practice authority, private equity, corporatization, and rethinking physician agency.

Read More

Cano Health’s Slow Demise

Cano Health's Slow Demise

After a long and beleaguered journey to this point, including a lengthy board fight, going concern…concerns, a $150M loan at a 14% interest rate for a year-long lifeline, and a rescheduled Q2 earnings conference call, Cano Health posted dismal results on its Q2 earnings release. The Medicare Advantage-focused senior clinic care platform reported a 103.5% medical loss ratio, meaning that for every premium dollar earned, Cano paid out 103.5% in medical costs. Good on them for subsidizing needed patient care!

Read More